Table 2 Surgical and pathological outcomes

From: Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

 

ILC ( n =177)

IDC ( n =1718)

 
 

No. of patients

%

No. of patients

%

χ 2 P -value

Final surgical outcome

Conservative

33

19

576

34

<0.001

Mastectomy

139

79

1078

63

 

No surgery

5

3

64

4

 

Pathological response

No pCR

165

93

1404

82

<0.001

pCR

6

3

246

14

 
  1. Abbreviations: IDC=invasive ductal carcinoma; ILC=invasive lobular carcinoma; pCR=pathological complete response.
Back to article page